Larvol Delta - Mosunetuzumab-in-Combination-With-Pirtobrutinib-in-Patients-With-Relapsed-or-Refractory-Waldenstrom-Macroglobulinemia-MPOWER

Jaypirca (pirtobrutinib) - Eli Lilly

Lunsumio (mosunetuzumab-axgb) - Roche

http://clinicaltrials.gov/ct2/show/NCT07548450

Sep 25, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next